Stock Watch: Cancer Combination Therapies Face Rising Bar
Additive Improvements Are Getting Harder To Demonstrate
Executive Summary
Improving efficacy by combining drugs has been a mainstay of cancer therapy but adding new targeted drugs together based on very early-stage data is not working out, especially when one of the drugs is barely active on its own.